116 related articles for article (PubMed ID: 9676794)
1. Local and systemic delivery of low molecular weight heparin following PTCA: acute results and 6-month follow-up of the initial clinical experience with the porous balloon (PILOT-study). Preliminary Investigation of Local Therapy Using Porous PTCA Balloons.
Oberhoff M; Baumbach A; Hermann T; Diehl C; Maier R; Athanasiadis A; Herdeg C; Bohnet A; Haase KK; Voelker W; Baildon R; Veldhof S; Karsch KR
Cathet Cardiovasc Diagn; 1998 Jul; 44(3):267-74. PubMed ID: 9676794
[TBL] [Abstract][Full Text] [Related]
2. Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo-Controlled Evaluation.
Karsch KR; Preisack MB; Baildon R; Eschenfelder V; Foley D; Garcia EJ; Kaltenbach M; Meisner C; Selbmann HK; Serruys PW; Shiu MF; Sujatta M; Bonan R
J Am Coll Cardiol; 1996 Nov; 28(6):1437-43. PubMed ID: 8917255
[TBL] [Abstract][Full Text] [Related]
3. [Low molecular weight heparin, reviparin, after PTCA: results of a randomized double-blind, standard heparin and placebo controlled multicenter study (REDUCE Study].
Preisack MB; Baildon R; Eschenfelder V; Foley D; Garcia E; Kaltenbach M; Meisner C; Selbmann HK; Serruys PW; Shiu MF; Sujatta M; Bonan R; Karsch KR
Z Kardiol; 1997 Aug; 86(8):581-91. PubMed ID: 9417748
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of conventional balloon angioplasty versus cutting balloon for in-stent restenosis. Acute and 24-hour angiographic and intravascular ultrasound changes and long-term follow-up.
Montorsi P; Galli S; Fabbiocchi F; Trabattoni D; Ravagnani PM; Bartorelli AL
Ital Heart J; 2004 Apr; 5(4):271-9. PubMed ID: 15185885
[TBL] [Abstract][Full Text] [Related]
5. Local and systemic delivery of low molecular weight heparin stimulates the reendothelialization after balloon angioplasty.
Oberhoff M; Novak S; Herdeg C; Baumbach A; Kranzhöfer A; Bohnet A; Horch B; Hanke H; Haase KK; Karsch KR
Cardiovasc Res; 1998 Jun; 38(3):751-62. PubMed ID: 9747444
[TBL] [Abstract][Full Text] [Related]
6. First clinical experience with low molecular weight heparin LU 47311 (reviparin) for prevention of restenosis after percutaneous transluminal coronary angioplasty.
Schmid KM; Preisack M; Voelker W; Sujatta M; Karsch KR
Semin Thromb Hemost; 1993; 19 Suppl 1():155-9. PubMed ID: 8395719
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of subcutaneous low molecular weight heparin (ardeparin) for reduction of restenosis after percutaneous transluminal coronary angioplasty.
Gimple LW; Herrmann HC; Winniford M; Mammen E
Am J Cardiol; 1999 Jun; 83(11):1524-9. PubMed ID: 10363865
[TBL] [Abstract][Full Text] [Related]
8. Time course of smooth muscle cell proliferation after local drug delivery of low-molecular-weight heparin using a porous balloon catheter.
Oberhoff M; Herdeg C; Baumbach A; Shamet K; Kranzhöfer A; Weingärtner O; Rübsamen K; Kluge M; Karsch KR
Cathet Cardiovasc Diagn; 1997 Jul; 41(3):268-74. PubMed ID: 9213025
[TBL] [Abstract][Full Text] [Related]
9. Incidence, outcome and prediction of early clinical events following percutaneous transluminal coronary angioplasty. A comparison between treatment with reviparin and unfractionated heparin/placebo (results of a substudy of the REDUCE trial).
Preisack MB; Bonan R; Meisner C; Eschenfelder V; Karsch KR
Eur Heart J; 1998 Aug; 19(8):1232-8. PubMed ID: 9740345
[TBL] [Abstract][Full Text] [Related]
10. Local heparin delivery prior to coronary stent implantation: acute and six-month clinical and angiographic results.
Bartorelli AL; De Cesare NB; Kaplan AV; Fabbiocchi F; Montorsi P; Squadroni L; Galli S; Sganzerla P; Loaldi A
Cathet Cardiovasc Diagn; 1997 Nov; 42(3):313-20. PubMed ID: 9367113
[TBL] [Abstract][Full Text] [Related]
11. Intracoronary radiotherapy with a (188)rhenium liquid-filled PTCA balloon system in in-stent restenosis: acute and long-term angiographic results, as well as 1-year clinical follow-up.
Reynen K; Köckeritz U; Kropp J; Wunderlich G; Knapp FF; Schmeisser A; Strasser RH
Int J Cardiol; 2004 May; 95(1):29-34. PubMed ID: 15159034
[TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparin (reviparin) reduces the incidence of femoropopliteal in-stent stenosis: preliminary results of an ongoing study.
Strecker EP; Göttmann D; Boos IB; Vetter S
Cardiovasc Intervent Radiol; 1998; 21(5):375-9. PubMed ID: 9853142
[TBL] [Abstract][Full Text] [Related]
13. Acute and one year follow-up results after vessel size adapted PTCA using intracoronary ultrasound.
Haase KK; Athanasiadis A; Mahrholdt H; Treusch A; Wullen B; Jaramillo C; Baumbach A; Voelker W; Meisner C; Karsch KR
Eur Heart J; 1998 Feb; 19(2):263-72. PubMed ID: 9519320
[TBL] [Abstract][Full Text] [Related]
14. Intramural drug delivery by direct injection within the arterial wall: first clinical experience with a novel intracoronary delivery-infiltrator system.
Pavlides GS; Barath P; Maginas A; Vasilikos V; Cokkinos DV; O'Neill WW
Cathet Cardiovasc Diagn; 1997 Jul; 41(3):287-92. PubMed ID: 9213027
[TBL] [Abstract][Full Text] [Related]
15. Porous balloon delivery of low molecular weight heparin in the dog coronary artery.
Baumbach A; Oberhoff M; Rübsamen K; Jochims K; Herdeg C; Kranzhöfer A; Safer A; Karsch KR
Eur Heart J; 1996 Oct; 17(10):1538-45. PubMed ID: 8909911
[TBL] [Abstract][Full Text] [Related]
16. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
[TBL] [Abstract][Full Text] [Related]
17. Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Initial results with a balloon-expandable, stainless steel design.
Hearn JA; King SB; Douglas JS; Carlin SF; Lembo NJ; Ghazzal ZM
Circulation; 1993 Nov; 88(5 Pt 1):2086-96. PubMed ID: 8222102
[TBL] [Abstract][Full Text] [Related]
18. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty.
Herrmann HC; Buchbinder M; Clemen MW; Fischman D; Goldberg S; Leon MB; Schatz RA; Tierstein P; Walker CM; Hirshfeld JW
Circulation; 1992 Sep; 86(3):812-9. PubMed ID: 1516193
[TBL] [Abstract][Full Text] [Related]
19. Laser balloon angioplasty combined with local intracoronary heparin therapy: immediate and short-term follow-up results.
Glazier JJ; Jiang AJ; Crilly RJ; Spears JR
Am Heart J; 1997 Aug; 134(2 Pt 1):266-73. PubMed ID: 9313607
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive intracoronary infusion of antithrombin III during percutaneous transluminal coronary angioplasty. Results of a prospective, randomized trial.
Schächinger V; Allert M; Kasper W; Just H; Vach W; Zeiher AM
Circulation; 1994 Nov; 90(5):2258-66. PubMed ID: 7955182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
